Home Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.
|

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.

Print
Share
Sign up for the
DRFZ NewsFlash